Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1993 1
1994 1
1997 1
1999 2
2001 1
2003 2
2004 2
2005 1
2006 10
2007 9
2008 13
2009 18
2010 16
2011 10
2012 12
2013 18
2014 15
2015 23
2016 8
2017 19
2018 5
2019 8
2021 1
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimitrova N, Leinonen MK, Siesling S, van der Zwan JM, Van Eycken L, Visser O, Žakelj MP, Anderson LA, Bella F, Kaire I, Otter R, Stiller CA, Trama A; RARECAREnet working group. Gatta G, et al. Among authors: comber h. Lancet Oncol. 2017 Aug;18(8):1022-1039. doi: 10.1016/S1470-2045(17)30445-X. Epub 2017 Jul 4. Lancet Oncol. 2017. PMID: 28687376 Free article.
Retraction.
Fitzgerald N, Comber H, O'Malley R, Dowling E, Wallace E, Lydon S, Murphy AW, Kelly ME. Fitzgerald N, et al. Among authors: comber h. Ir Med J. 2025 Dec 10;118(10):184. Ir Med J. 2025. PMID: 41379418 No abstract available.
Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study.
Miyoshi J, Mannucci A, Scarpa M, Gao F, Toden S, Whitsett T, Inge LJ, Bremner RM, Takayama T, Cheng Y, Bottiglieri T, Nagtegaal ID, Shrubsole MJ, Zaidi AH, Wang X, Coleman HG, Anderson LA, Meltzer SJ, Goel A; FINBAR-EMERALD collaborative group. Miyoshi J, et al. Gut. 2025 Jan 17;74(2):169-181. doi: 10.1136/gutjnl-2024-333364. Gut. 2025. PMID: 39562048
Comparative cancer survival information in Europe.
Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R; EUROCARE Working Group. Berrino F, et al. Eur J Cancer. 2009 Apr;45(6):901-8. doi: 10.1016/j.ejca.2009.01.018. Epub 2009 Feb 13. Eur J Cancer. 2009. PMID: 19217771 No abstract available.
The burden of rare cancers in Europe.
Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group. Gatta G, et al. Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17. Adv Exp Med Biol. 2010. PMID: 20824452 Review.
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. Ray-Coquard I, et al. Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Eur J Surg Oncol. 2019. PMID: 29108961 Review.
Multiple tumours in survival estimates.
Rosso S, De Angelis R, Ciccolallo L, Carrani E, Soerjomataram I, Grande E, Zigon G, Brenner H; EUROCARE Working Group. Rosso S, et al. Eur J Cancer. 2009 Apr;45(6):1080-94. doi: 10.1016/j.ejca.2008.11.030. Epub 2009 Jan 2. Eur J Cancer. 2009. PMID: 19121933
167 results